PRP vs cortisone: which may help sooner?

Which treatment tends to help first?

Cortisone often brings relief sooner, though the relief may fade. Gel and blood-based care can take more time.

PRP means platelet-rich plasma, made when staff spin a sample of your arm blood. The spin gathers platelets, small blood parts that help stop bleeding.

Clinics use that liquid in hopes of easing joint soreness. Still, no treatment can promise how your knee will respond.

A sudden flare might ease after a quieter day and light motion. If the ache returns again, an exam may narrow the cause.

You haven't failed when home care isn't enough. Get the joint checked before spending money on a treatment.

What do orthobiologics include?

Orthobiologics covers treatments that use your blood or marrow. Concentrated PRP is the blood choice above, with more platelets held in less liquid.

Marrow care starts when clinic staff take marrow from your pelvis. A machine then spins the marrow before it is used.

The word concentrate means the wanted parts sit in less liquid. This visit isn't the same as a simple arm blood draw.

QC Kinetix provides regenerative treatment options made with those blood or marrow sources. Its medical providers, the trained staff who examine and care for you, guide the visit.

You'll talk about your soreness and any past care. The provider can also explain knee or hip surgery alternatives.

Is PRP clearly better than cortisone or gel?

There isn't one winner for every knee. Cortisone may help sooner, while PRP may help more after several months.

Other research found no clear difference between those choices. Gel also helps some knees but makes little change for others.

Ask how the suggested care fits the ache you feel today. You don't need to choose from a chart alone.

An exam matters before money changes hands. When soreness stays steady, you'll have time to weigh the choices.

Sources

1. A meta-analysis of 18 Level I trials (811 PRP vs 797 HA patients, mean follow-up 11.1 months) found mean WOMAC total improvement of 44.7% with PRP versus 12.6% with HA (P<.01). Six of 11 VAS-based studies and 3 of 6 IKDC-based studies favoured PRP significantly. In the subanalysis, leukocyte-POOR PRP was associated with significantly better subjective IKDC scores than leukocyte-rich PRP.

   Belk JW, et al. — Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials.. American Journal of Sports Medicine, 2021. DOI: 10.1177/0363546520909397.

2. A meta-analysis of 27 Level I studies (1,042 PRP, 226 BMAC, 1,128 HA patients) found significantly better post-injection WOMAC, VAS and subjective IKDC scores for BOTH PRP and BMAC compared with hyaluronic acid - and NO significant difference between PRP and BMAC on any outcome score. This is the clearest published statement that the two most-marketed orthobiologics perform the same as each other in the knee.

   Belk JW, et al. — Patients With Knee Osteoarthritis Who Receive Platelet-Rich Plasma or Bone Marrow Aspirate Concentrate Injections Have Better Outcomes Than Patients Who Receive Hyaluronic Acid: Systematic Review and Meta-analysis.. Arthroscopy, 2023. DOI: 10.1016/j.arthro.2023.03.001.

3. A randomized trial allocated 175 patients with KL II-IV knee OA to BMAC (n=111), PRP (n=34) or hyaluronic acid (n=30) and followed them for 12 months. All three produced significant improvement from baseline in WOMAC, KOOS and IKDC with no serious side effects; BMAC showed significantly better clinical improvement than PRP and HA on most scores, and PRP scored higher than HA without reaching statistical significance. Note the unequal, non-blinded design - this is the strongest direct BMAC-versus-PRP randomized comparison available, and it is not a strong design.

   Dulic O, et al. — Bone Marrow Aspirate Concentrate versus Platelet Rich Plasma or Hyaluronic Acid for the Treatment of Knee Osteoarthritis.. Medicina (Kaunas), 2021. DOI: 10.3390/medicina57111193.

4. A 2024 systematic review of eight randomized trials (937 patients) found BMAC improved pain and function from baseline and beat hyaluronic acid on pain at 6 and 12 months, but the differences did NOT exceed the minimal clinically important difference, and no significant differences emerged against other injectables.

   Han JH, et al. — Bone Marrow Aspirate Concentrate Injections for the Treatment of Knee Osteoarthritis: A Systematic Review of Randomized Controlled Trials.. Orthop J Sports Med, 2024. DOI: 10.1177/23259671241296555.

5. A Bayesian network meta-analysis of 48 Level I-II randomized trials (9,338 knees) with a minimum 6-month follow-up ranked the four commonest intra-articular injections. HA and PRP both significantly improved pain versus placebo; HA, PRP and BMAC all significantly improved function versus placebo. SUCRA rankings were PRP 91.54, BMAC 76.46, HA 53.12, corticosteroid 15.18 and placebo 13.70 - corticosteroid ranked barely above placebo at six months and beyond.

   Jawanda H, et al. — Platelet-Rich Plasma, Bone Marrow Aspirate Concentrate, and Hyaluronic Acid Injections Outperform Corticosteroids in Pain and Function Scores at a Minimum of 6 Months as Intra-Articular Injections for Knee Osteoarthritis: A Systematic Review and Network Meta-analysis.. Arthroscopy, 2024. DOI: 10.1016/j.arthro.2024.01.037.

6. A network meta-analysis of 43 trials (5,554 patients) reached the OPPOSITE ranking to the more recent orthobiologic-favourable reviews: steroids ranked most likely to be effective for pain and function, with adipose MSC and multiple PRP ranked LEAST likely; single PRP, multiple PRP and adipose MSC did not produce a relevant reduction in pain or improvement in function versus placebo. The authors noted treatment-effect differences were small and potentially not clinically meaningful either way.

   Han SB, et al. — Intra-Articular Injections of Hyaluronic Acid or Steroids Associated With Better Outcomes Than Platelet-Rich Plasma, Adipose Mesenchymal Stromal Cells, or Placebo in Knee Osteoarthritis: A Network Meta-analysis.. Arthroscopy, 2021. DOI: 10.1016/j.arthro.2020.03.041.

7. A network meta-analysis of 79 RCTs (8,761 patients) covering eleven injectables - autologous conditioned serum, BMAC, botulinum toxin, corticosteroid, HA, MSC, ozone, saline placebo, PRP, PRGF and stromal vascular fraction - found the top-ranked treatment CHANGES WITH TIME POINT: high-molecular-weight HA plus corticosteroid ranked first for WOMAC at 4-6 weeks and 3 months, while PRP ranked first at 6 months. This is the clearest demonstration that 'which injection is best' depends entirely on when you measure.

   Anil U, et al. — The efficacy of intra-articular injections in the treatment of knee osteoarthritis: A network meta-analysis of randomized controlled trials.. The Knee, 2021. DOI: 10.1016/j.knee.2021.08.008.

8. A Bayesian network meta-analysis restricted to trials with at least one year of follow-up (37 RCTs, 5,089 patients) ranked combined PRP+HA first for both pain relief and function at one year, ahead of PRP alone, then HA+corticosteroid, then HA alone, then placebo, with corticosteroid alone ranked LAST - below placebo.

   Gupta N, et al. — Long-term effectiveness of intra-articular injectables in patients with knee osteoarthritis: a systematic review and Bayesian network meta-analysis.. Journal of Orthopaedic Surgery and Research, 2025. DOI: 10.1186/s13018-025-05574-w.

9. A 2026 network meta-analysis of 21 RCTs (2,254 patients) found both leukocyte-rich and leukocyte-poor PRP significantly superior to placebo and to hyaluronic acid for function at 6-12 months (MD vs placebo -13.20 and -10.54 respectively). LP-PRP ranked highest (P-score 0.96) but the DIRECT comparison between the two formulations showed no statistically significant difference, and the authors concluded there is insufficient evidence to recommend one PRP formulation over the other.

   Xu B, et al. — Leukocyte-rich versus leukocyte-poor platelet-rich plasma and hyaluronic acid for knee osteoarthritis: a systematic review and network meta-analysis.. Journal of Orthopaedic Surgery and Research, 2026. DOI: 10.1186/s13018-026-06689-4.

10. RESTORE, the largest and most rigorously blinded placebo-controlled PRP trial in knee OA (n=288, participant-, injector- and assessor-blinded), gave three weekly injections of a commercial leukocyte-poor PRP or saline. At 12 months the change in knee pain was -2.1 vs -1.8 points (difference -0.4; 95% CI -0.9 to 0.2; P=.17) and the change in medial tibial cartilage volume was -1.4% vs -1.2% (difference -0.2%; P=.81). Twenty-nine of 31 prespecified secondary outcomes showed no between-group difference. The authors concluded the findings do not support the use of PRP for knee OA.

    Bennell KL, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.. JAMA, 2021. DOI: 10.1001/jama.2021.19415.

11. FDA states verbatim of stem cell products, stromal vascular fraction (adipose-derived cells), umbilical cord blood, Wharton's jelly, amniotic fluid and exosome products: 'None of these products have been approved for the treatment of any orthopedic condition, such as osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain, or shoulder pain.' The only FDA-approved stem cell products in the United States are blood-forming (hematopoietic progenitor) cells derived from umbilical cord blood, approved only for disorders of blood production, and there are currently NO FDA-approved exosome products.

    U.S. Food and Drug Administration — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. FDA (Center for Biologics Evaluation and Research), 2020.

12. A Bayesian network meta-analysis of 35 studies (3,104 participants) found PRP and PRP plus hyaluronic acid most successful for function and pain at 3, 6 and 12 months, and found no increase in treatment-related adverse events for corticosteroid, hyaluronic acid, PRP or combination therapy versus placebo.

    Qiao X, et al. — Efficacy and safety of corticosteroids, hyaluronic acid, and PRP and combination therapy for knee osteoarthritis: a systematic review and network meta-analysis.. BMC Musculoskelet Disord, 2023. DOI: 10.1186/s12891-023-06925-6.